Immuneering
IMRX
$1.41
Share price
2.17%
Change (1 day)
-18.02%
Change (1 year)
Categories
Revenue for Immuneering (IMRX)
Revenue in 2024 (TTM): N/A
a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Immuneering from 2020 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2024  | N/A | |
| 2023 | N/A | -100% |
| 2022 | $0.31 M | -84.76% |
| 2021 | $2.07 M | -10.02% |
| 2020 | $2.31 M |